These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20064476)

  • 1. Vaccine adjuvants: a priority for vaccine research.
    Harandi AM; Medaglini D; Shattock RJ;
    Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference.
    Ross AL; Bråve A; Scarlatti G; Manrique A; Buonaguro L
    Lancet Infect Dis; 2010 May; 10(5):305-16. PubMed ID: 20417413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine adjuvants: scientific challenges and strategic initiatives.
    Harandi AM; Davies G; Olesen OF
    Expert Rev Vaccines; 2009 Mar; 8(3):293-8. PubMed ID: 19249971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and challenges in mucosal adjuvant technology.
    Newsted D; Fallahi F; Golshani A; Azizi A
    Vaccine; 2015 May; 33(21):2399-405. PubMed ID: 25865473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we entering a new age for human vaccine adjuvants?
    O'Hagan DT; Fox CB
    Expert Rev Vaccines; 2015 Jul; 14(7):909-11. PubMed ID: 25947042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal immunity on the banks of the Duoro.
    Lavelle EC; Thanavala Y; Ogra P
    Hum Vaccin; 2009 May; 5(5):281-3. PubMed ID: 19229136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in nanoparticle-based vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing vaccine development.
    Hoft DF; Brusic V; Sakala IG
    Cell Microbiol; 2011 Jul; 13(7):934-42. PubMed ID: 21631691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine adjuvants: smart components to boost the immune system.
    Bastola R; Noh G; Keum T; Bashyal S; Seo JE; Choi J; Oh Y; Cho Y; Lee S
    Arch Pharm Res; 2017 Nov; 40(11):1238-1248. PubMed ID: 29027637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IABS international scientific workshop--Mode of Action of Adjuvants: implications for vaccine safety and design, April 29-30, 2010, Bethesda, MD, USA.
    Seemann S; Dodet B
    Vaccine; 2011 Apr; 29(17):3340. PubMed ID: 21335035
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in vaccine adjuvants.
    Schijns VE; Lavelle EC
    Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine adjuvants: key tools for innovative vaccine design.
    Riese P; Schulze K; Ebensen T; Prochnow B; Guzmán CA
    Curr Top Med Chem; 2013; 13(20):2562-80. PubMed ID: 24066891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The path forward.
    De Gregorio E
    Vaccine; 2015 Jun; 33 Suppl 2():B60-3. PubMed ID: 26022572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of adjuvants: the future of vaccine design.
    Mount A; Koernig S; Silva A; Drane D; Maraskovsky E; Morelli AB
    Expert Rev Vaccines; 2013 Jul; 12(7):733-46. PubMed ID: 23885819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12th Annual Conference on Vaccine Research.
    O'Brien J
    Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine adjuvants.
    Reed SG
    Expert Rev Vaccines; 2013 Jul; 12(7):705-6. PubMed ID: 23885812
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-33 isoforms: their future as vaccine adjuvants?
    Villarreal DO; Weiner DB
    Expert Rev Vaccines; 2015 Apr; 14(4):489-92. PubMed ID: 25656504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine adjuvant safety: the elephant in the room.
    Petrovsky N
    Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvants: no longer a 'dirty little secret', but essential key players in vaccines of the future.
    Arakawa T
    Expert Rev Vaccines; 2011 Jan; 10(1):1-5. PubMed ID: 21162613
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.